Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
07/2003
07/24/2003US20030138518 Center-filled chewing gum containing a deliverable form of calcium
07/24/2003US20030138501 A concentrate solution comprising sodium bicarbonate concentrate, electrolyte concentrate; treating renal failure with hemofiltration
07/24/2003US20030138430 Drug combinations containing an agent that arrests target cells in the G2 (cell enlargement) and/or M phase (DNA replication) of the cell cycle and another drug that targets an internalising cell surface structure e.g. an antigen
07/24/2003US20030138386 Niobium, vanadium, antimony, tantalum, strontium, calcium, magnesium, barium, molybdenum or silicon oxides; paints, plastics, coatings, pigments, dyes and sunscreens
07/24/2003US20030138384 Introgducing long chain polyphosphate to mammalian teeth by a non-acidic beverage so the teeth will be protected from a later attack by an acidic beverage; treating dental erosion, preventing dental discoloration
07/24/2003CA2472160A1 Quinazolinone compounds in combined modalities for improved cancer treatment
07/24/2003CA2471192A1 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
07/24/2003CA2469156A1 Center-filled chewing gum containing calcium
07/24/2003CA2467764A1 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions.
07/24/2003CA2440455A1 Bicarbonate-based solutions for dialysis therapies
07/23/2003EP1329434A2 Use of micronized materials as an additive to bricks
07/23/2003EP1329221A1 Polymeric micelle containing cisplatin enclosed therein and use thereof
07/23/2003EP1328288A2 Protein mixtures for wound healing
07/23/2003EP1328267A2 Method of treating cancer using dithiocarbamate derivatives
07/23/2003EP1328253A2 Administration of a thiol-based chemoprotectant compound
07/23/2003EP1328156A1 Composition for generating chlorine dioxide
07/23/2003EP1173154A4 Chewing gum with dental benefits including calcium in a food grade acid
07/23/2003EP0969849B1 Stable solid preparation containing vitamin d3 and tricalcium phosphate
07/23/2003EP0820290B1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
07/23/2003CN1431910A Ginsenoside chemotherapy
07/23/2003CN1431909A Combinations for treating neoplasms
07/23/2003CN1431874A Use of polyphosphate as tooth erosion inhibitor in acidic compsns.
07/23/2003CN1431007A Combination of external remedy for treating skin disease and venereal disease
07/23/2003CN1430998A Drip pills for curing aphtha and its preparing method
07/23/2003CN1430984A Detoxification capsule and its prodn. methods
07/23/2003CN1430970A Application of Nano copper powder for preparing medicine for prophylaxis of osteoporosis and bone fracture
07/23/2003CN1115167C Medical compsn. for treating leukoderma
07/23/2003CN1115157C Liver recovery decoction for treating liver disease and its prepn. method
07/23/2003CN1115154C Piles medicine
07/23/2003CN1115153C Medicine synergist
07/23/2003CN1115142C Deodorising powder
07/23/2003CN1115106C Environmentally compatible processes, compsns. and materials treated thereby
07/22/2003US6596762 Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
07/22/2003US6596712 Administering an effective amount of cytotoxic chemical compound selected from nitrosourea, cyclophophamide, doxorubicin, 5-fluorouracil, cisplatin etc. in first treatment of cancer and squalamine in second treatment step
07/22/2003US6596320 Combination regimen of platinum agent, taxane agent and toxicity reducing agent such as cisplatin, paclitaxel and dimesna
07/22/2003US6595956 Drug delivery device
07/17/2003WO2003057250A1 Cancer treatment
07/17/2003WO2003057233A1 Composition for preventing or treating mastitis of dairy cattle
07/17/2003WO2003057228A1 Carbon dioxide compositions for external use and process for producing the same
07/17/2003WO2003057225A2 Phosphate transport inhibitors
07/17/2003WO2003057211A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases.
07/17/2003WO2003057206A1 Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
07/17/2003WO2003057201A2 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
07/17/2003WO2003056951A2 Antimicrobial body covering articles
07/17/2003US20030135196 Irrigating via the flow pathway the area of the hemorrhage with a synthetic cerebrospinal fluid to reduce an indication of the presence of blood in effluent from the outflow catheter.
07/17/2003US20030134893 Combination chemotherapy
07/17/2003US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as
07/17/2003US20030134804 Rehydrating formulation
07/17/2003US20030134315 Testing a sample from a cancer patient for the expression of a negative signal transduction factor (NSTF) and for the expression of a positive signal transduction factor (PSTF), selecting chemotherapeutic agent for treatment based on above
07/17/2003US20030134027 Comprises pectin, alginate, calcium, and fiber; dietetics
07/17/2003US20030133996 Ruminant animal feed, and mineral supplement and method of use
07/17/2003US20030133995 Neutralizing amount of casein protein, or salt thereof, alkali earth metal halide, water; to neutralize effect of capsaicin on oral cavity, tongue, and esophagus
07/17/2003US20030133994 Administration of a combination regimen of a platinum agent, a taxane agent, and a formula I toxicity-reducing agent
07/17/2003US20030133992 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
07/17/2003US20030133991 Composition containing zinc ions, calcium ions, rubidium ions and/or potassium ions in carrier, which, when applied to open wound, modulates activity of MMP-2 and/or MMP- 9 in wound; ulcer treatment
07/17/2003US20030133990 Bandage using molecular sieves
07/17/2003US20030133985 Controlled release oral dosage forms; data obtained using disintegration test such as the established USP Disintegration Test, rather than the results obtained using a standard USP Dissolution Test, as is conventionally done
07/17/2003US20030133959 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
07/17/2003US20030133878 Composition for the treatment of legionella pneumophila and a method for such treatment
07/17/2003US20030133354 Passing the fluid between two electrodes, a first electrode being formed of a metal having dielectric covering , a second electrode being formed of a metal and being grounded, applying a direct current voltage to first eelctrode
07/17/2003US20030131844 Inducing hypothermia and rewarming using a helium-oxygen mixture
07/17/2003CA2472893A1 Cancer treatment
07/17/2003CA2471932A1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
07/17/2003CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
07/16/2003EP1327453A1 Stable taurolidine electrolyte solutions
07/16/2003EP1326621A2 Medicinal composition and in particular its use in fluid therapy
07/16/2003EP1326583A1 Medication delivery devices
07/16/2003EP1326502A2 Method for preparing a mixture that can be granulated and carnitine-magnesium hydroxycitrate
07/16/2003EP1104675A4 Agent for regulating iodine exchange or for preventing iodine-deficit conditions
07/16/2003EP1079798B1 Odour absorbing agent
07/16/2003CN1430515A Divided dose therapies with vascular damaging activity
07/16/2003CN1429626A Upper digestive tract cancer primary screening general investigation test solution
07/16/2003CN1429616A New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method
07/16/2003CN1429559A Anti-adhesion isolator
07/16/2003CN1114444C Natural product capable of stimulating lactation of domestic animal
07/16/2003CN1114442C Burns treating ointment
07/16/2003CN1114440C Medicine for treating toothache
07/16/2003CN1114437C Medicated wine
07/16/2003CN1114423C External used liquid for treating tumour, hyperplastic surgical disease
07/16/2003CN1114422C Anti-cancer Chinese-medicinal pill
07/16/2003CN1114417C Medicine for treating fungus diseases
07/16/2003CN1114416C Application of arsenious acid in preparing medicine for treating gynecologic tumor and lymphomatosis
07/16/2003CN1114415C Medicine for curing enteritis and bacillary dy sentery
07/16/2003CN1114403C Vitronectin receptor antagonists
07/16/2003CN1114361C Solid composition for reducing tooth erosion
07/15/2003US6593362 Non-peptidic cyclophilin binding compounds and their use
07/15/2003US6592908 Nutritional or therapeutic compositions
07/15/2003US6592907 Treating an eye infections; cleansing a contact lens in place on an eye
07/15/2003US6592890 Conveyance of anti-infective activity to wound dressings
07/15/2003US6592848 Ready to use aerosol packages
07/15/2003US6591872 Process and plant for the dynamic packaging of gases, especially those for medical use
07/15/2003CA2139864C Use of a calcium carbonate based porous material as support for a growth factor in the preparation of a bioabsorbable implant
07/15/2003CA2095889C Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
07/10/2003WO2003055864A1 Long chain fatty alcohol substituents in antineoplastic agents
07/10/2003WO2003055804A1 Calcium carbonate of different shapes and the preparing process thereof
07/10/2003WO2003055501A1 The use of hydrochloric acid in the preparation of a medicament for the treatment of tumour
07/10/2003WO2003055500A1 Pharmaceutical compositions for the treatment or prevention of osteoporosis
07/10/2003WO2003055469A1 Improved polymer-lipid delivery vehicles
07/10/2003WO2003037298A3 Bowel cleansing agent
07/10/2003US20030130227 Uridine derivatives as antibiotics
1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 563